Two New Bills Present Challenges to DNA Patentability
This time the challenge to the patents, commonly called gene patents, comes from the US House of Representatives in the form of two bills introduced on March 15 by Rep. Lynn Rivers (D-Mich.). If enacted, each of these would threaten future biotech innovation in the US.